Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
JAMA Neurology|July 9, 2019
Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical TrialLon S Schneider, Ronald G Thomas, Suzanne Hendrix, et al.
Sleep Medicine: X|March 16, 2023
The relative contribution of COVID-19 infection versus COVID-19 related occupational stressors to insomnia in healthcare workersRebecca C Hendrickson, Catherine A McCall, Aaron F Rosser, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2022
The relative contribution of COVID-19 infection versus COVID-19 related occupational stressors to insomnia in healthcare workersRebecca C Hendrickson, Catherine A McCall, Aaron F Rosser, et al.
Journal of General Internal Medicine|December 17, 2021
The Impact of the COVID-19 Pandemic on Mental Health, Occupational Functioning, and Professional Retention Among Health Care Workers and First RespondersRebecca C Hendrickson, Roisín A Slevin, Katherine D Hoerster, et al.
JAMA|June 5, 2003
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trialPaul S Aisen, Kimberly A Schafer, Michael Grundman, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Instability in longitudinal sleep duration predicts cognitive impairment in aged participants of the Seattle Longitudinal StudySamantha A Keil, Abigail G Schindler, Marie X Wang, et al.
Neurology|September 13, 2015
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer diseaseR Scott Turner, Ronald G Thomas, Suzanne Craft, et al.
Archives of Neurology|March 21, 2012
Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measuresDouglas R Galasko, Elaine Peskind, Christopher M Clark, et al.
Alzheimer'S Research & Therapy|June 12, 2015
Peripheral and central effects of γ-secretase inhibition by semagacestat in Alzheimer's diseaseRachelle S Doody, Rema Raman, Reisa A Sperling, et al.
Alzheimer'S Research & Therapy|May 29, 2020
The Alzheimer's Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer's diseaseJessica B Langbaum, Noel N Ellison, Angelika Caputo, et al.
Pageof 9